12/5
04:27 pm
slrx
Salarius Pharmaceuticals (NASDAQ:SLRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Salarius Pharmaceuticals (NASDAQ:SLRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
12/1
08:00 am
slrx
Salarius Pharmaceuticals to Collaborate with Texas Biomedical Research Institute on Avian Flu Study
Medium
Report
Salarius Pharmaceuticals to Collaborate with Texas Biomedical Research Institute on Avian Flu Study
11/29
03:38 pm
slrx
Salarius Pharmaceuticals (NASDAQ:SLRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Salarius Pharmaceuticals (NASDAQ:SLRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/24
01:53 pm
slrx
Salarius Pharmaceuticals (NASDAQ:SLRX) is now covered by analysts at
Weiss Ratings. They set a "sell (e+)" rating on the stock.
Low
Report
Salarius Pharmaceuticals (NASDAQ:SLRX) is now covered by analysts at
Weiss Ratings. They set a "sell (e+)" rating on the stock.
11/19
04:45 pm
slrx
Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol “SLRX” [Yahoo! Finance]
Low
Report
Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol “SLRX” [Yahoo! Finance]
11/19
02:42 pm
slrx
Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol “SLRX”
Medium
Report
Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol “SLRX”
11/13
07:07 pm
slrx
Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger [Yahoo! Finance]
Low
Report
Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger [Yahoo! Finance]
11/13
08:45 am
slrx
Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger
Low
Report
Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger
11/11
09:18 am
slrx
Salarius Pharmaceuticals Announces Pricing of $7 Million Underwritten Public Offering
High
Report
Salarius Pharmaceuticals Announces Pricing of $7 Million Underwritten Public Offering
10/13
09:10 am
slrx
Salarius Pharmaceuticals Regains Compliance with All Nasdaq Listing Requirements [Yahoo! Finance]
Low
Report
Salarius Pharmaceuticals Regains Compliance with All Nasdaq Listing Requirements [Yahoo! Finance]
10/13
09:09 am
slrx
Salarius regains full Nasdaq compliance ahead of planned merger with Decoy Therapeutics [Seeking Alpha]
Low
Report
Salarius regains full Nasdaq compliance ahead of planned merger with Decoy Therapeutics [Seeking Alpha]
10/13
08:45 am
slrx
Salarius Pharmaceuticals Regains Compliance with All Nasdaq Listing Requirements
Medium
Report
Salarius Pharmaceuticals Regains Compliance with All Nasdaq Listing Requirements
9/9
08:28 am
slrx
Salarius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement [Yahoo! Finance]
Medium
Report
Salarius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement [Yahoo! Finance]
9/9
08:00 am
slrx
Salarius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
Medium
Report
Salarius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement